Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Cancer

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2011.04.021PMID 21600761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dependence receptors: a new paradigm in cell signaling and cancer therapy

  2010cited by this paper
• N-cadherin is depleted from proximal tubules in experimental and human acute kidney injury

  2010cited by this paper
• Loss of expression of TIMP3 in clear cell renal cell carcinoma.

  2010cited by this paper
• p53 and MDM2 in renal cell carcinoma

  2010cited by this paper
• Multigene Methylation Analysis of Conventional Renal Cell Carcinoma

  2009cited by this paper
• The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIMEL

  2009cited by this paper
• Changes in UNC5C gene methylation during human gastric carcinogenesis.

  2009cited by this paper
• Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.

  2009cited by this paper
• Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.

  2007cited by this paper
• The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma

  2007cited by this paper
• Netrins: beyond the brain

  2007cited by this paper
• Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies.

  2007cited by this paper
• Epidemiologic aspects of renal cell carcinoma.

  2006cited by this paper
• Promoter hypermethylation of the potential tumor suppressor DAL‐1/4.1B gene in renal clear cell carcinoma

  2006cited by this paper
• Renal-cell carcinoma.

  2005cited by this paper
• Netrin-1 and its receptors in tumorigenesis

  2004cited by this paper
• The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.

  2003cited by this paper
• Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations.

  2003cited by this paper
• The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment

  2003cited by this paper
• Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters

  2002cited by this paper
• Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.

  2001cited by this paper
• An 8-cM interstitial deletion on 4q21-q22 in DNA from an infant with hepatoblastoma overlaps with a commonly deleted region in adult liver cancers.

  2001cited by this paper
• Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.

  2000cited by this paper
• Novel mutations of the von Hippel‐Lindau tumor‐suppressor gene and rare DNA hypermethylation in renal‐cell carcinoma cell lines of the clear‐cell type

  2000cited by this paper
• Cloning and mapping of the UNC5C gene to human chromosome 4q21-q23.

  1998cited by this paper
• P53, bcl-2, and Bax expression in renal cell carcinoma.

  1998cited by this paper
• A modified and improved method for bisulphite based cytosine methylation analysis.

  1996cited by this paper
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995cited by this paper
• Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

  1994cited by this paper

• FBLN2 promoter hypermethylation: a negative prognostic biomarker and anti-PD-1 response predictor in clear cell renal cell carcinoma via high-throughput CpG Island screening

  2025influential citation
• Single-cell sequencing technology in renal cancer: insights into tumor biology and clinical application

  2025cites this paper
• Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles

  2024cites this paper
• Identification and validation of HOXD3 and UNC5C as molecular signatures in keloid based on weighted gene co-expression network analysis.

  2022cites this paper
• Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer

  2021cites this paper
• A global integrated analysis of UNC5C down-regulation in cancers: insights from mechanism and combined treatment strategy.

  2021cites this paper
• UNC5 dependence receptor family in human cancer: A controllable double-edged sword.

  2021cites this paper
• UNC5A, an epigenetically silenced gene, functions as a tumor suppressor in non-small cell lung cancer

  2020cites this paper
• UNC5D, suppressed by promoter hypermethylation, inhibits cell metastasis by activating death‐associated protein kinase 1 in prostate cancer

  2019cites this paper
• Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability

  2017cites this paper
• Methylation of the UNC5C gene and its protein expression in colorectal cancer

  2017cites this paper
• Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective.

  2016cites this paper
• DNA Methylation and Flavonoids in Genitourinary Cancers

  2015cites this paper
• Role of DNA methylation in renal cell carcinoma

  2015cites this paper
• Effective Population Size, Extended Linkage Disequilibrium and Signatures of Selection in the Rare Dog Breed Lundehund

  2015cites this paper
• Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles.

  2014cites this paper
• Erratum: An iteration normalization and test method for differential expression analysis of RNA-seq data

  2014cites this paper
• IQGAP3 Promotes EGFR-ERK Signaling and the Growth and Metastasis of Lung Cancer Cells

  2014cites this paper
• Netrin-1 Expression Is an Independent Prognostic Factor for Poor Patient Survival in Brain Metastases

  2014cites this paper
• Author ' s response to reviews Title : An iteration normalization and test method for differential expression analysis of RNA-seq data

  2014cites this paper
• An iteration normalization and test method for differential expression analysis of RNA-seq data

  2014cites this paper
• Protein Kinase C (PKC) Isozymes and Cancer

  2014cites this paper
• [Dependence receptors: life or death choices].

  2013cites this paper
• Reduced expression of Slit2 in renal cell carcinoma

  2013cites this paper
• The Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma

  2013cites this paper
• Proteomics and the search for biomarkers for renal cancer.

  2013cites this paper
• Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome.

  2012cites this paper